Published • loading... • Updated
Grail’s Cancer Blood Test Faces High-Stakes FDA Review
The panel will weigh whether Galleri can reliably detect up to 50 cancers and whether false results justify approval.
- On Wednesday, the Medical Devices Advisory Committee meets to vote on whether benefits of Grail's Galleri test outweigh risks such as false alarms and missed cancers.
- Grail Inc. designed the Galleri test to screen for up to 50 Cancer forms by identifying DNA fragments shed by tumor cells in the bloodstream, aiming to supplement standard Cancer screenings.
- Advisers are evaluating two major studies involving more than 140,000 patients, though the test failed to meet its primary goal of reducing late-stage Cancer diagnoses over three years.
- Currently priced at $949, the test lacks FDA approval but would spur insurance coverage from Medicare and private insurers if cleared, dramatically widening access for Americans.
- The committee's decision acts as a bellwether for the industry, as hundreds of companies chase similar blood-test technology. Cristian Tomasetti, director of City of Hope's early detection division, said approval would validate "the overall concept" of early Cancer detection.
Insights by Ground AI
24 Articles
24 Articles
Grail’s cancer blood test faces high-stakes FDA review – WTOP News
WASHINGTON (AP) — A blood test designed to spot signs of multiple cancers in apparently healthy people faces its first major regulatory hurdle Wednesday as advisers to the U.S. government review how well it works. Grail Inc.’s test looks for DNA fragments shed by tumor cells, an emerging approach to screening that aims to detect...
·Chevy Chase, United States
Read Full Article
Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote
The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts will decide if the test should be recommended for FDA approval.
·San Diego, United States
Read Full Article
FDA panel puts Grail’s cancer screening to the test
·Arlington County, United States
Read Full ArticleCoverage Details
Total News Sources24
Leaning Left11Leaning Right1Center8Last UpdatedBias Distribution55% Left
Bias Distribution
- 55% of the sources lean Left
55% Left
L 55%
C 40%
Factuality
To view factuality data please Upgrade to Premium
